Life Sciences
The Challenge
New York has the resources to become a world-leading Life Sciences center but needs improved access to top talent and continued exposure to advanced technologies.
The Initiative
New York State’s Life Sciences Initiative aims to attract top medical talent, spur R&D, and foster life sciences innovation through a $650 million investment in a research cluster in the state. Sectors directly impacted by the initiative include biotechnology, pharmaceuticals, biomedical technologies, and life systems technologies.
According to some estimates, Israel is responsible for 25% of the world’s biotech solutions.
Nearly 1 in 3 Israeli scientists specializes in life sciences, working for one of the country’s 1,400 life sciences companies.
Israel is also widely considered a global center for healthcare R&D, with the the country spending 4.3% of its GDP on medial research.
According to some estimates, Israel is responsible for 25% of the world’s biotech solutions. Continuing to build on New York’s existing 26 Israeli healthcare companies may bring strong life sciences R&D to the state.
See More: NY-Israel Economic Impact Report